drugset / Trial / NCT01905605

Phosphatidylcholine Supplementation in Infants

NCT01905605

Phase 1/2 Withdrawn University of Colorado, Denver
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Sensory gating is defined as the automatic process of inhibiting brain response to repeated auditory sounds. Infants who brains respond similarly to two identical sounds presented about 1/2 second apart are more likely to have later problems with attention than infants who suppress response to the second sound. This study will examine whether providing a nutritional supplement, phosphatidylcholine, for two months in infancy will result in an increased likelihood of developing more robust sensory gating.

Timeline

Start
2013-09
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Choline Other / unclassified 700 mg

Indications